本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Nuvectis Pharma, Inc.

8.99
-0.2300-2.49%
盤後8.990.00000.00%18:57 EDT
成交量:12.41萬
成交額:111.57萬
市值:2.10億
市盈率:-7.97
高:9.43
開:9.19
低:8.81
收:9.22
資料載入中...
2022/02/02

SEC問詢函

CORRESP [Cover] - Correspondence
2022/01/24

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/01/18

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/01/18

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/11/30

SEC問詢函

CORRESP [Cover] - Correspondence
2021/11/30

SEC問詢函

CORRESP [Cover] - Correspondence
2021/11/30

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/11/26

SEC問詢函

CORRESP [Cover] - Correspondence
2021/11/26

SEC問詢函

CORRESP [Cover] - Correspondence
2021/11/09

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/11/08

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/11/04

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/11/02

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/10/28

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/10/21

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/10/20

SEC問詢函

CORRESP [Cover] - Correspondence
2021/10/06

SEC問詢函

CORRESP [Cover] - Correspondence
2021/10/06

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933